Author
Listed:
- Ana Rita González
(Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico)
- Lizbeth Alexandra Acuña Merchán
(Cuenta de Alto Costo, Cra. 45 #103 34 Oficina 802, Bogotá 110111, Colombia)
- Jorge A. Alatorre Alexander
(Health Pharma Professional Research S.A de C.V., Av. Insurgentes Sur 662-Piso 3, Col. Del Valle, Benito Juárez, Ciudad de México 03100, Mexico)
- Diego Kaen
(Centro Oncologico Riojano Integral, La Rioja F5300, Argentina)
- Catalina Lopez-Correa
(Genome Canada, 50 Metcalfe Street, Suite 2100, Ottawa, ON K2P 1P1, Canada)
- Claudio Martin
(Alexander Fleming Institute, Av. Crámer 1180—C1426ANZ, Buenos Aires C1426, Argentina)
- Allira Attwill
(Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico)
- Teresa Marinetti
(Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico)
- João Victor Rocha
(Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico)
- Carlos Barrios
(LACOG—Latin American Cooperative Oncology Group, Porto Alegre 91900-580, Brazil)
Abstract
This study presents and discusses evidence on the value of biomarker testing and precision medicine in Latin America through a health equity lens. It is essential to explore how to harness the benefits of precision medicine to narrow the health equity gap, ensuring all patients have access to the best cancer treatment. The methodology employed to develop this document consists of a non-systematic literature review, followed by a process of validation and feedback with a group of experts in relevant fields. Precision medicine could help reduce health inequities in Latin America by providing better diagnosis and treatment for everyone with cancer. However, its success in achieving this depends on the implementation of policies that promote equitable access. Findings indicate that the current policy landscape in the Latin American region is not conducive to improving access, reach, quality, or outcome-related problems in cancer care, nor to realizing the full potential of precision medicine. The study explores how precision medicine can advance health equity, concluding with an analysis of the challenges and recommendations for overcoming them.
Suggested Citation
Ana Rita González & Lizbeth Alexandra Acuña Merchán & Jorge A. Alatorre Alexander & Diego Kaen & Catalina Lopez-Correa & Claudio Martin & Allira Attwill & Teresa Marinetti & João Victor Rocha & Carlos, 2025.
"Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping,"
IJERPH, MDPI, vol. 22(8), pages 1-55, August.
Handle:
RePEc:gam:jijerp:v:22:y:2025:i:8:p:1220-:d:1718027
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:22:y:2025:i:8:p:1220-:d:1718027. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.